Health status and burden of late effects in very long-term testicular cancer survivors. - STANDBY-study

niversitair Medisch Centrum Groningen0 个研究点目标入组 280 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•Three groups of TC survivors will be included: treated with surgery and chemotherapy (CT group), surgery and radiotherapy (RT group) or surgery only (SU group). We also will include a control group (CO group) of healthy volunteers who have not been treated for any type of cancer. The groups will be age matched with te patients from the CT group, a margin of three years will be accepted.;Inclusion criteria for both TC survivors as controls:
•1. Age <70 years at time of inclusion
•2. Signed informed consent;Additional inclusion criteria for CT-group:
•3. Patients treated with cisplatin-based chemotherapy for TC good or intermediate IGCCCG prognosis.
•4. Age at start of TC treatment <40 yrs.
•5. At least 20 years after start of treatment for TC at time of inclusion.;Additional inclusion criteria for RT-group:
•3. Patients treated with radiotherapy for TC stage I or II.
•4. Age at start of TC treatment < 40 yrs.
•5. At least 20 years after start of treatment for TC at time of inclusion.;Additional inclusion criteria for SU- group:
•3. Patients treated with orchidectomy only for TC stage I.
•4. Age at start of TC treatment < 40 yrs.
•5. At least 20 years after start of treatment for TC at time of inclusion.

•Exclusion criteria for both TC survivors as controls:
•1. Mental disability (no informed consent available).;Additional exclusion criteria for CT-group:
•2. Patients also treated with radiotherapy for TC.;Additional exclusion criteria for RT-group:
•2. Patients also treated with chemotherapy for TC.;Additional exclusion criteria for SU-group:
•2. Patients also treated with chemo- or radiotherapy for TC.;Additional exclusion criteria for CO-group:
•2. Treated with chemotherapy, radiotherapy or hormonal therapy for any type of cancer.

发起方